Filing Details

Accession Number:
0001104659-22-036105
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-21 16:06:00
Reporting Period:
2022-03-18
Accepted Time:
2022-03-21 16:06:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1173281 Neubase Therapeutics Inc. NBSE Pharmaceutical Preparations (2834) 465622433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1765274 P. Todd Branning C/O 350 Technology Drive, Fourth Floor
Pittsburgh PA 15219
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-18 10,000 $1.81 30,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct